CD23 serves as a marker for B cells, notably in diseases such as SLL (Small Lymphocytic Lymphoma)/CLL, diffuse follicular lymphoma, and mediastinal large B cell lymphoma [85]. This evidence concerns the gene FCER2 and B-cell chronic lymphocytic leukemia.